Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![sfbionetwork Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1142831555850592256.png) San Francisco Biotechnology Network [@sfbionetwork](/creator/twitter/sfbionetwork) on x 2026 followers
Created: 2025-07-17 02:06:14 UTC

Nature Medicine Published Phase X Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma #news #biotech


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945666320877457864/c:line.svg)

**Related Topics**
[$1801hk](/topic/$1801hk)

[Post Link](https://x.com/sfbionetwork/status/1945666320877457864)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

sfbionetwork Avatar San Francisco Biotechnology Network @sfbionetwork on x 2026 followers Created: 2025-07-17 02:06:14 UTC

Nature Medicine Published Phase X Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma #news #biotech

XX engagements

Engagements Line Chart

Related Topics $1801hk

Post Link

post/tweet::1945666320877457864
/post/tweet::1945666320877457864